Romsey – 10 October 2011 – Stratophase, innovators in real-time in situ monitoring and diagnostics, will be presenting a talk entitled “Optical microchip sensors for multiplexed detection of biological agents” at this year’s Bio-Sensing conference in Amsterdam, the Netherlands, 10-12 October. The presentation by Devaki Bhatta, Stratophase’s Head of Biodetection, will outline the latest developments in bio-detection solutions utilising the company’s proprietary SpectroSens™ optical microchip technology.
By using light to measure change, Stratophase’s unique technology brings precision, flexibility and cost-effectiveness to real-time monitoring and diagnostics. SpectroSens microchip bio-detector is coated with specific antibodies that bind with high specificity and affinity to biological targets. When a given toxin, bacteria or virus is present in the sample it binds and triggers a positive detection. One disposable SpectroSens microchip can be used to test multiple samples simultaneously, or several biological targets within a single sample.
To find out more, meet Stratophase at Bio-Sensing 2011 Amsterdam (10th to 12th October), or see the website at www.stratophase.com.
About Stratophase:
Stratophase is a VC-funded spin-out from the University of Southampton in the UK. Its unique technology is an optical microchip sensor which measures chemical processes and detects biological targets. This core optical measurement technology can be realised in a vast array of sensing heads, offering a wide variety of system configurations applicable to a broad spectrum of industries including biochemical production as well as biological detection.
The Stratophase team includes the original inventors of the SpectroSens technology as well as senior managers with a vast array of industry experience.
